FDA Regulation of Food Contact and Packaging Material
When a consumer opens a can of soda or bag of potato chips, they have little knowledge of the scientific and legal resources invested in that can, bag, beverage, or chip. Food packaging, for instance, incorporates a variety of strategic decisions for producers: how well does the packaging preserve the product, how easy is it to distribute, how appealing is it to consumer tastes? Layered atop these decisions are a host of regulatory issues, including packaging safety to labeling accuracy.
While the U.S. Food and Drug Administration (FDA), charged with regulating Food Contact Substances (FCS), has simplified the approval process for food packaging and food additives, the process remains detailed and requires significant strategic decision-making to bring products effectively and efficiently to market. Bergeson & Campbell, P.C. (B&C®) professionals, who include in-house polymer chemists and other scientists, provide clients the legal and scientific know-how to navigate the regulatory process while keeping an eye on the end-goal of consumer appeal.
B&C professionals offer clients a combination of legal, strategic, and scientific expertise. That combination is key to assisting clients in bringing their products to market, staying on top of regulatory issues, and responding effectively to matters that may arise over the course of a product's life.
Attorney Jayne Bultena has almost 20 years of experience in food and drug regulatory matters. She has counseled Fortune 100 companies, start-ups, and venture capital investors across issues, including FDA inspections, responding to deficiencies, and coordinating press and media relations. She has represented clients before FDA, the U.S. Consumer Product Safety Commission (CPSC), and the U.S. Federal Trade Commission (FTC).
Regulatory consultant Karin Baron, M.S.P.H., has an extensive track record of chemical regulatory work. Prior to joining B&C she served as manager of FDA compliance for a major specialty chemical company, among other roles, and her 15 years of industry experience are a tremendous asset to clients in matters regarding food contact notifications.
Jason Johnston, M.S., holds two Master of Science degrees in Chemical Engineering Practice and in Technology and Policy from the Massachusetts Institute of Technology. He has more than 25 years of experience in the field of risk assessment. Mr. Johnston has served as the project manager/senior scientist for a diverse range of risk assessments and is well-versed in the preparation of residential, dietary, and consumer product exposure assessments.
Dr. David Peveler, holding a Ph.D. in organic chemistry, is expert in product regulatory compliance, FDA food contact and packaging matters, and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) product registration and labeling matters. Prior to joining B&C, Dr. Peveler served as a consultant to Evonik Degussa Corporation and as Senior Regulatory Scientist with Chemtura Corporation. His portfolio includes directing research in a variety of areas involving polymer additives, including PVC heat stabilizers and polymeric plasticizers, and antioxidants for polyolefins.
Dr. Jane Vergnes, DABT®, a toxicologist with a Ph.D. in Human Genetics and 25 years of experience with global chemical companies, advises clients on the science and strategy needed to demonstrate that materials are safe for the intended FDA-regulated use. Dr. Vergnes offers considerable expertise in designing and monitoring toxicology studies for diverse materials, including food packaging, lubricants for food processing machinery, preservatives, personal care ingredients, pharmaceutical excipients, and tablet coatings.
Dr. Brian Xu, M.D., Ph.D., DABT® has over 15 years of industry experience as a senior toxicologist and scientist at major chemical companies. He assists clients in designing safety testing, risk assessment, product safety, and regulatory compliance programs. Dr. Xu's significant experience with FDA regulations and with the Orders and Decrees of the Chinese regulatory system helps him anticipate potential hurdles for clients registering or marketing products in either jurisdiction.
B&C often partners with its consulting affiliate, The Acta Group (Acta®). Acta professionals bring technical and business expertise to strategic planning, product approvals, and advocacy. Between B&C's business and legal professionals and Acta's scientific professionals, clients have a broad knowledge base to draw from in navigating through the FDA approval process.
What We Do:
B&C's professionals have extensive experience assisting clients in obtaining appropriate authority to market FCSs. Our client counsel includes the following:
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Ave, N.W. Suite 100W | Washington, D.C. 20037 | (202) 557-3800 • (202) 557-3836 (fax) | www.lawbc.com
© 2017 Bergeson & Campbell, P.C. All Rights Reserved